A 55-year-old post-menopausal woman with type 2 diabetes has an HbA1c of 7.8%. Which medication is preferred to reduce cardiovascular mortality in a patient with established heart failure?
-
A
SGLT-2 inhibitor (empagliflozin)
-
B
GLP-1 receptor agonist
-
C
Metformin
-
D
Sulfonylurea